Can Indian pharma companies beat the regulatory odds?

November 2, 2016Posted By Admin

Regulatory issues from US FDA(Food and Drug Administration) have created stir among pharma companies and have soured investor sentiment towards pharma stocks. But this is not the final and with its structural advantages India is going to play much bigger role in $1.2trillion global pharma market. Increase level of import alerts, export ban, warning letters […]


We are social 24/7 - Get in touch